Risk of Recurrent Neurologic Stroke or Transient Ischemic Attack in Patients with Cryptogenic Stroke and Intrapulmonary Shunt
Echocardiography 33:276-280, Sinha, R.S.,et al, 2015
An unusual cause of stroke and hypoxia
BMJ 342:c7200, Bell, S.L. & Eveson, D.J., 2011
Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia: A Series of 126 Patients
Medicine 86:1-7, Cottin,V.,et al, 2007
Cerebrovascular Manifestations in 321 Cases of Hereditary Hemorrhagic Telangiectasia
Stroke 32:877-882, Maher,C.O.,et al, 2001
Neurological Manifestations of Hereditary Hemorrhagic Telangiectasia (Rendu-Osler-Weber Disease)
Ann Neurol 4:130-144, Roman,G.,et al, 1978
Neurologic Aspects of Hereditary Hemorrhagic Telangiectasia
Arch Neurol 34:101, Adams,H.P.,et al, 1977
Cryptogenic Stroke
NEJM 374:2065-2074, Saver, J.L., 2016
Closure Versus Medical Therapy for Preventing Recurrent Stroke in Patients with Patent Foramen Ovale and a History of Cryptogenic Stroke or Transient Ischemic Attack
Stroke 47:e188-e189, Li, J.,et al, 2016
Diagnostic Yield of Pelvic Magnetic Resonance Venography in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Stroke 45:2324-2329, Liberman, A.L.,et al, 2014
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012
Neurological Complications of Sclerotherapy for Varicose Veins
J Vasc Surg 55:243-251, Sarvananthan, T.,et al, 2012
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011
Study Design of the CLOSURE I Trial: A Prospective, Multicenter, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System Versus Best Medical Therapy in Patients With Stroke or TIA Due to Presumed Paradoxical Embolism Through a PFO
Stroke 41:2872-2883, Furlan,A.J.,et al, 2010
Recurrent Cerebral Ischemia in Medically Treated Patent Foramen Ovale: A Meta-Analysis
Neurol 73:89-97,84, Almekhlafi,M.A.,et al, 2009
Antithrombotic and Interventional Treatment Options in Cardioembolic Transient Ischaemic Attack and Ischaemic Stroke
JNNP 78:14-24, McCabe,D.J.H. &Rakhit,R.D., 2007
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 37:577-617, Sacco,R.L.,et al, 2006
Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004
Recurrent Thromboembolic Events After Percutaneous Device Closure of Patent Foramen Ovale
ICVTS 2:125-127, Brgermann,J.,et al, 2003
The Association Between the Diameter of a Patent Foramen Ovale and the Risk of Embolic Cerebrovascular Events
Am J Med 109:456-462,506, Schuchlenz,H.W.,et al, 2000
Detection of Patent Foramen Ovale. Transesophageal Echocardiography and Transcranial Doppler Sonography With Ultrasound Contrast Media are "Supplementary, Not Competing, Diagnostic Methods"
Med Klin 94:367-370, Heckmann,J.G.,et al, 1999
Transient Ischaemic Attacks Related to Carotid Stenosis Precipitated by Straining, Bending, and Sneezing
Postgrad Med J 75:145-146, Harrison, M.J.G., 1999
The Need to Quantify Right-to-Left Shunt in Acute Ischemic Stroke, A Case-Control Study
Stroke 29:1322-1328, Serena,J.,et al, 1998
Transient Ischemic Attacks Caused by Trumpet Playing
Neurol 51:1709-1710, Evers,S.,et al, 1998
Case Record of MGH-NEJM Subdural Hematoma Secondary to Metastasis & Lacunar Infarcts
286:650, , 1972
Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010
A Patient with Left Ventricular Thrombus and Recurrent Stereotypic TIAs
Neurol 65:492-493, Bower,C.M.,et al, 2005
Rapidly Reversible Dementia
Lancet 361:392, Bernstein,R.,et al, 2003
Cerebrovascular Complication Associated with Pulmonary Vein Ablation
J Cardiovasc Electrophysiol 13:764-767, Kok,L.C.,et al, 2002
Anticardiolipin Antibodies & the Risk of Recurrent Thrombo-Occlusive Events & Death
The Antiphospholipid Antibodies & Stroke Study Group, Neurol 48:91-9497., , 1997
Predictive Value of Clin Hx & EKG in Pts with TIA or Minor Stroke for Sub Cardiac & Cerebral Ischemic Events
Arch Neurol 51:333-341, Pop,G.A.M.,et al, 1994
Left Ventricular Mass and Risk of Stroke in an Elderly Cohort:The Framingham Heart Study
JAMA 272:33-36, 711994., Bikkina,M.,et al, 1994
Silent Infarcts in Patients with Ischemic Stroke are Related to Age and Size of the Left Atrium
Stroke 24:1347-1351, Mounier-Vehier,F.,et al, 1993
Radiofrequency Ablation of Kent's Pathways. Apropos of 30 Cases
Arch Mal Coeur Vaiss 86:307-312, Sadoul,N.,et al, 1993
Enhanced Detection of Intracardiac Sources of Cerebral Emboli by Transeophageal Echocardiography
Stroke 22:734-739, Lee,R.J.,et al, 1991
Limitations of EEG Monitoring in the Detection of Cerebral Ischemia Accompanying Carotid Endarterectomy
J Vasc Surg 13:439-443, Kresowik,T.F.,et al, 1991
Vertebrobasilar Ischemia after Neck Motion
Stroke 22:1452-1460, Frisoni,G.B.&Anzola,G.P., 1991
Frequency, Etiology, and Prevention of Stroke in Patients with Systemic Lupus Erythematosus
Stroke 20:583-591, Futrell,N.&Millikan,C., 1989
Sarcoidosis Presenting with Stroke
Stroke 20:400-405, Brown,M.M.,et al, 1989
Results of the Seven-Year Prospective Study of Stroke Patients
Stroke 19:942-949, Scmidt,E.V.,et al, 1988
Neurologic Manifestations in Sarcoidosis
Ann Int Med 87:336, Delaney,P., 1977
Central Nervous System Manifestations of Periarteritis Nodosa
Neurol 15:114, Ford,R.G.,et al, 1965